News

08.01.2019

"It doesn't always have to stay the same"

Désirée Mettraux has been the CEO of Creadi since 2016. The Pax spin-off has developed the Simpego online insurance platform. The insurance expert is confident that the industry will profit if it opens itself up to partners. The aim is to make insurance fun.

mehr >
15.01.2019

BC Platforms bietet neue Dienstleistungen an

BC Platforms bietet neue Dienstleistungen an

Das Basler Unternehmen BC Platforms entwickelt neue Angebote im Bereich der Forschung für die Pharma- und Gesundheitsbranche. Dazu hat es eine Zusammenarbeit mit der finnischen MedEngine vereinbart.

mehr >
14.01.2019

Basel researchers identify drug against the formation of metastasis

Basel researchers identify drug against the formation of metastasis

Scientists from the University of Basel and the University Hospital of Basel have discovered a drug that suppresses the formation of metastases. Metastases are reponsible for 90% of all cancer-related fatalities.

mehr >
03.12.2018

“Momentum for blockchain in healthcare is growing in Basel”

“Momentum for blockchain in healthcare is growing in Basel”

Marco Cuomo and Daniel Fritz from Novartis got engaged in blockchain two years ago. Today, their aim is set high: With other pharma companies under the Innovative Medicines Initiative, they formed a “Blockchain Enabled Healthcare” program, due to kick off in 2019. The program that they presented at the Blockchain Leadership Summit in Basel – Switzerland’s largest conference in this field - wants no less than to define how blockchain is applied in healthcare.

mehr >
10.01.2019

Basler Kantonalbank launches innovation subsidiary

Basler Kantonalbank launches innovation subsidiary

Keen Innovation AG launched in January. The subsidiary of Basler Kantonalbank develops and tests new products for the bank and Bank Cler.

mehr >
08.01.2019

Unitelabs automating lab work

Unitelabs has produced software that enables the automation of processes in life science laboratories. The spin-off from the Swiss Federal Institute of Technology in Zurich plans to move into its own offices in Basel soon.

mehr >
23.11.2018

Expats like Basel best

Expats like Basel best

Expats find Basel to be the best city in Switzerland, according to a study published by InterNations. Six Swiss cities were analyzed as part of its latest Expat City Ranking.

mehr >
07.01.2019

Infographic: The Basel Biotech & Pharma Ecosystem

To develop a scientific discovery into a life-changing drug or technology, it takes experts from various fields. The Basel region provides all of the crucial ingredients needed to foster innovation. BaseLaunch and Labiotech.eu created an infographic that shows all the important players in Basel’s Biotech and Pharma ecosystem.

mehr >
07.01.2019

Centre for abdominal disorders opens in Basel

The Clarunis centre for abdominal disorders has now opened in Basel. Jointly established by the University Hospital Basel and Claraspital, the new centre will strengthen the position of top-notch medicine in the Basel region and promote research.

mehr >
14.11.2018

Roivant raised USD 200 million, now valued at USD 7 billion

Roivant raised USD 200 million, now valued at USD 7 billion

The Basel-based pharmaceutical company Roivant Sciences has raised USD 200 million in a funding round. As a result, the company is now valued at an estimated USD 7 billion.

mehr >
07.01.2019

Le Groupe RECOMATIC soigne l’état de surface du luxe suisse

Le Groupe RECOMATIC soigne l’état de surface du luxe suisse

Rencontre au cœur des champs d’un petit village jurassien, entre traditions rurales voisines et haute précision mécanique. Entretien avec le co-directeur du Groupe, Monsieur Christophe Rérat.

mehr >
18.12.2018

Basel researchers search for new data storage devices

Basel researchers and their international colleagues are exploring new methods for controlling the physical state of individual molecules within a network. Their work could result in the development of new storage devices.

mehr >
05.11.2018

Three entrepreneurs, three visions of Industry 4.0

Dominik Trost (holo|one), Philippe Kapfer (NextDay.Vision), Roy Chikballapur (MachIQ)

BaselArea.swiss invited startups and Industry 4.0 projects to participate in the first Industry 4.0 Challenge. A jury from the industry chose three finalists: Philippe Kapfer with NextDay.Vision, Roy Chikballapur with MachIQ and Dominik Trost with holo|one. Learn more about their contributions and visions in the interview. You can meet the entrepreneurs at the Salon Industries du Futur Mulhouse on 20 and 21 November 2018.

mehr >
14.12.2018

The long tail in healthcare

The long tail in healthcare

Can the treatment of rare disorders be a role model for healthcare innovation in precision medicine? This was the question at this years’ last edition of the DayOne Experts event series. The answer was, simply put: Yes.

mehr >
13.12.2018

Belles rencontres pour nos 3 gagnants du concours i4Challenge 2018 au salon Industrie du Futur

Belles rencontres pour nos 3 gagnants du concours i4Challenge 2018 au salon Industrie du Futur

Sur deux jours, la 4ème édition du salon a réuni plus de 3500 visiteurs, 230 stands sur la thématique de l’industrie 4.0. En plus des visites de stands, les organisateurs ont proposé un nombre impressionnant de conférences, talks et pitches ainsi que des rendez-vous d’affaires. Une bonne ambiance professionnelle à régner sur le salon avec des visiteurs de qualité. Trouvait des offreurs de solutions, des entreprises de services, des écoles, des startups.

mehr >
27.09.2018

"I Was Always One of Few Women in the Industry"

SOLO Swiss in Porrentruy in the canton of Jura has been making industrial furnaces for heat-treating metals since 1924. The family company with a global presence is developing against the backdrop of Industry 4.0 and is struggling to find the qualified workforce which is indispensable for what it does amid the effects of the strong franc and what are sometimes restrictive administrative regulations. Interview with Anne-Sophie Spérison, President and CEO.

mehr >
13.12.2018

Basel blockchain forum starts with a bang

Basel blockchain forum starts with a bang

Hyperledger, the international blockchain initiative, is currently hosting the first Hyperledger Global Forum in Basel. As the event opened, the initiative welcomed numerous renowned companies as new members.

mehr >
11.12.2018

Resistell closes successful financing round

Resistell closes successful financing round

Resistell has closed on oversubscribed seed financing round. The Basel-based startup is developing an antibiotic susceptibility test that is much faster than conventional tests.

mehr >
04.09.2018

“Our business is the most beautiful business in the world”

“Our business is the most beautiful business in the world”

Giacomo di Nepi has a successful history: A high level executive in big corporations, he transitioned towards biotech, currently as CEO of Polyphor, which, in May 2018, he led to the IPO. We spoke to Giacomo about serving patients, the timing for an IPO and the people needed in a biotech.

mehr >
10.12.2018

Swiss freight metro clears major hurdle

Swiss freight metro clears major hurdle

CST AG, the initiator of the freight metro, has secured new shareholders – and with them, a Swiss majority for the planning permission phase. In doing so, the project has fulfilled one of the requirements of the Federal Council, which can now begin the consultation process for special CST legislation.

mehr >
06.12.2018

Basel software developer raises new capital

jacando has closed another successful financing round. The Basel software company is currently in the process of creating new jobs.

mehr >
15.07.2018

Basel pharma companies invest most in R&D

Basel pharma companies invest most in R&D

The 24 Interpharma companies spent a total of 96 billion Swiss francs on research and development worldwide in 2017. Of this, 7 billion francs were invested in Switzerland. When compared with the sales they generated in Switzerland, the companies’ Swiss research investment was more than twice as high. According to the association, this is a testament to the great significance of Switzerland as a research location and the innovation taking place at these companies.

mehr >
04.12.2018

Le Jura sur la liaison ferroviaire internationale Bienne-Belfort

Les trains vont à nouveau circuler entre Delle et Belfort dès le dimanche 9 décembre. Ce nouveau tronçon sera mis à l’honneur lors de la prochaine édition du forum économique franco-suisse, programmée le 28 mars 2019 à Belfort.

mehr >
04.12.2018

BaselArea.swiss fights antimicrobial resistance as a part of the CARB-X Global Accelerator Network

BaselArea.swiss fights antimicrobial resistance as a part of the CARB-X Global Accelerator Network

Antibiotic resistance is fatal: If antibiotics have no effect, simple infections become deadly. According to the World Health Organization, an estimated 700,000 people die each year worldwide from bacterial infections. Additionally, research on new antibiotics had been drastically reduced in the last decades. However, companies in the Basel region such as Basliea, BioVersys, Idorsia, Polyphor and Roche as well as the University of Basel and the FHNW are pursuing the field of antimicrobial resistance (AMR).

mehr >
13.07.2018

Basel has the biggest economic potential

Basel has the biggest economic potential

Basel has the biggest economic potential in Europe, according to a new study from BAK Economics. The city on the bend of the Rhine ranked particularly well for competitiveness, while Geneva and Zurich also came in the top five.

mehr >
04.12.2018

The creative power of the chemical industry

The creative power of the chemical industry

At our innovation event on 15 November, the participants got to know the creative power of Chemspeed in Füllinsdorf in the canton of Basel-Landschaft. Chemspeed was founded just 21 years ago, employs 150 people today and ships their products worldwide. 70 participants used the opportunity to tour the company and to indulge in the latest trends in automated chemical labs.

mehr >
03.12.2018

BaselArea.swiss welcomes CMAB to Basel

BaselArea.swiss welcomes CMAB to Basel

In autumn 2018, CMAB Biopharma AG opened its International Office in Basel. Basel is the first location for CMAB outside of China and enables deployment of their world class monoclonal antibody and biologics development and manufacturing services internationally.

mehr >
03.07.2018

"Processes Kill Innovation"

The serial entrepreneur Neil Goldsmith is drawn to new ventures. We spoke to him about discovering talent suitable for start-ups and about his current involvement with BaseLaunch.

mehr >
03.12.2018

«Le grand challenge c’est l’innovation et bien comprendre les besoins des clients»

«Le grand challenge c’est l’innovation et bien comprendre les besoins des clients»

Patrick Fleury, co-propriétaire de la société CLA SA – Clinical Laboratory Automation SA à Delémont nous introduit sur son parcours d’entrepreneur au Jura.

mehr >
03.12.2018

So navigieren Unternehmen die Digitale Transformation

So navigieren Unternehmen die Digitale Transformation

«Jedes Unternehmen hat Chancen in einer digitalen Zukunft». Davon ist abiliCor überzeugt, das erste Spin-off der Hochschule für Wirtschaft FHNW. Es unterstützt und begleitet Unternehmen auf dem Weg der Digitalen Transformation.

mehr >
17.06.2018

Most exciting biotechs are based in Basel

Biotechs based in Basel

Basel is among the European biotech hubs with the most exciting companies as named by labiotech.eu. The industry platform highlighted businesses including Actelion and Polyphor.

mehr >
03.12.2018

Three projects to start in the DayOne Accelerator

Three projects to start in the DayOne Accelerator

DayOne and BaselArea.swiss are happy to announce the winners of the first DayOne Accelerator supported by Fondation Botnar:

mehr >
30.11.2018

Basel scientists receive European grant

Basel scientists receive European grant

The European Research Council has awarded Consolidator Grants to two Basel scientists – Malte Helmert and Lukas Jeker. The highly qualified young researchers will receive at least two million euros over five years for their projects.

mehr >
11.06.2018

“Basel has all the ingredients required to host a successful company”

“Basel has all the ingredients required to host a successful company”

The physician and pharmacologist Nicole Onetto is a member of the Board of Directors at the Basilea Pharmaceutica AG. In the Interview that was featured in Basilea’s annual report she talks about current challenges in oncology.

mehr >
27.11.2018

BC Platforms assists UK’s biobanking platform

BC Platforms assists UK’s biobanking platform

Data management company BC Platforms has entered into a research cooperation with the University of Nottingham to integrate clinical and genetic data into the UK’s national biobank network.

mehr >
26.11.2018

Polyphor wins Swiss Technology Award

Polyphor wins Swiss Technology Award

Polyphor has won the Swiss Technology Award in the Innovation Leader category. The biopharmaceutical company from the Basel region has a portfolio that includes innovative antibiotics.

mehr >
05.06.2018

"We will not shy away from taking risks"

In 2016, Roivant Sciences established their global headquarters in Basel. Roivant founder and CEO Vivek Ramaswamy talked to us about his fast growing company, his priorities for the company and about the role that Roivant aims to play in the Basel life sciences ecosystem.

mehr >
26.11.2018

Santhera and Idorsia join forces

Santhera and Idorsia join forces

Pharmaceutical company Santhera is acquiring a drug candidate from Idorsia. With the sale price to be partially received as shares, Idorsia will become the biggest shareholder in Santhera.

mehr >
20.11.2018

GETEC acquires Infrapark Baselland

The energy services provider GETEC is acquiring Infrapark Baselland AG and its activities from the chemicals company Clariant. GETEC also intends to acquire Novartis’s facilities in the neighbouring Schweizerhalle, thus boosting the site’s attractiveness.

mehr >
08.05.2018

“IP protection is crucial for business and research”

“IP protection is crucial for business and research”

The patent law and attorney-at-law firm Vossius & Partner has been an important partner for BaseLaunch since the inception of the healthcare accelerator in 2016. They advise startups and big corporations alike on IP strategy. Philipp Marchand, patent attorney in the Basel office, advocates to take IP protection seriously.

mehr >

 

(Source: http://www.baselarea.swiss/en/baselarea-swiss/channels/innovation-report.html)